Reply: Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis: Older Age at Diagnosis, a Substitute for Older Age?
作者信息
Desai Sameer, Wong Hubert, Sykes Jenna, Stephenson Anne L, Singer Joel, Quon Bradley S
机构信息
1 University of British Columbia Vancouver, British Columbia.
3 St. Michael's Hospital Toronto, Ontario, Canada and.
出版信息
Ann Am Thorac Soc. 2019 May;16(5):644-645. doi: 10.1513/AnnalsATS.201901-063LE.
Abstract
摘要
相似文献
1
Reply: Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis: Older Age at Diagnosis, a Substitute for Older Age?回复：成人诊断为囊性纤维化后生存时间缩短的预测因素：诊断时年龄较大，是高龄的替代指标？
Ann Am Thorac Soc. 2019 May;16(5):644-645. doi: 10.1513/AnnalsATS.201901-063LE.
2
Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis: Older Age at Diagnosis, a Substitute for Older Age?成人诊断为囊性纤维化后生存降低的预测因素：诊断时年龄较大，是高龄的替代因素吗？
Ann Am Thorac Soc. 2019 May;16(5):644. doi: 10.1513/AnnalsATS.201812-896LE.
3
Cystic fibrosis birth rates in Canada: a decreasing trend since the onset of genetic testing.加拿大囊性纤维化的出生率：自基因检测开始以来呈下降趋势。
J Pediatr. 2005 Sep;147(3):312-5. doi: 10.1016/j.jpeds.2005.06.043.
4
[Italian Cystic Fibrosis Register - Report 2010].[意大利囊性纤维化登记处——2010年报告]
Epidemiol Prev. 2016 Mar-Apr;40(2 Suppl 2):1-47. doi: 10.19191/EP16.2S2.P001.074.
5
After the Celebrations: Lessons from the New Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy.庆祝之后：囊性纤维化跨膜传导调节因子调节剂治疗新时代的经验教训
Ann Am Thorac Soc. 2019 Feb;16(2):189-190. doi: 10.1513/AnnalsATS.201810-664ED.
6
Correlation between mutations and age in cystic fibrosis in a French Canadian population.法裔加拿大人群中囊性纤维化患者的突变与年龄之间的相关性。
J Med Genet. 2000 Mar;37(3):225-7. doi: 10.1136/jmg.37.3.225.
7
How do cystic fibrosis transmembrane conductance regulator mutations produce lung disease?囊性纤维化跨膜传导调节因子突变如何导致肺部疾病？
Curr Opin Pulm Med. 1995 Nov;1(6):435-43. doi: 10.1097/00063198-199511000-00002.
8
Rate of Uptake of Ivacaftor Use after U.S. Food and Drug Administration Approval among Patients Enrolled in the U.S. Cystic Fibrosis Foundation Patient Registry.美国食品和药物管理局批准后，纳入美国囊性纤维化基金会患者注册中心的患者中伊伐卡托使用率。
Ann Am Thorac Soc. 2015 Aug;12(8):1146-52. doi: 10.1513/AnnalsATS.201504-214OC.
9
Modeling cystic fibrosis disease progression in patients with the rare CFTR mutation P67L.对携带罕见CFTR突变P67L的患者的囊性纤维化疾病进展进行建模。
J Cyst Fibros. 2017 May;16(3):335-341. doi: 10.1016/j.jcf.2017.03.008. Epub 2017 Apr 5.
10
[Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].[意大利囊性纤维化注册机构（ICFR）。2015 - 2016年报告]
Epidemiol Prev. 2019 Jul-Aug;43(4S1):1-36. doi: 10.19191/EP19.4.S1.067.
本文引用的文献
1
Clinical Characteristics and Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis. Analysis of the Canadian CF Registry.成人诊断的囊性纤维化的临床特征和生存时间降低的预测因素。加拿大 CF 登记处分析。
Ann Am Thorac Soc. 2018 Oct;15(10):1177-1185. doi: 10.1513/AnnalsATS.201801-037OC.
Zotero 插件